0G5M4ZZ
Destruction Superior Parathyroid Gland, Left to No Qualifier with No Device, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | G Endocrine System |
| Operation | 5 Destruction |
| Body Part | M Superior Parathyroid Gland, Left |
| Approach | 4 Percutaneous Endoscopic |
| Device | Z No Device |
| Qualifier | Z No Qualifier |
Operation Definition
Physical eradication of all or a portion of a body part by the direct use of energy, force, or a destructive agent
Procedure Overview
Destruction procedures in the endocrine system eliminate abnormal or diseased tissue in a gland, such as a thyroid nodule, adrenal mass, or pituitary lesion, using energy sources like radiofrequency, laser, cryotherapy, or chemical agents rather than by cutting the tissue out. The gland or the surrounding tissue is not physically removed from the body; it is destroyed in place and the body absorbs or walls off the treated area over time.
This approach is often chosen for patients who are not good candidates for surgical removal, for smaller lesions that do not require full excision, or when preserving as much of the surrounding healthy gland tissue as possible is a priority, such as with certain benign thyroid nodules treated by ablation.
Anatomy & Axis Detail
Superior Parathyroid Gland, Left
The left superior parathyroid gland lies on the posterior surface of the left thyroid lobe and, together with three other parathyroid glands, maintains calcium homeostasis through parathyroid hormone secretion. Nonsurgical destruction in place is considered for a hyperfunctioning left superior gland when ablative therapy, such as ultrasound-guided ethanol injection or radiofrequency ablation, is chosen over parathyroidectomy, often in patients with recurrent or persistent hyperparathyroidism after prior surgery or those unfit for another operative procedure. Because superior parathyroid glands arise embryologically from the fourth pharyngeal pouch and are usually found in a fairly constant location near the cricothyroid junction, preprocedural imaging such as ultrasound or sestamibi scanning is used to confirm the correct gland before treatment. Accurate documentation of laterality and superior position is essential, since this glands's location and function are coded separately from the inferior or right-sided parathyroid glands.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Coding & Documentation
The operative note should describe an energy-based or chemical method used to eradicate tissue in place, with no portion of the gland physically excised or taken out. Coders need to identify the exact energy source and gland involved, since the approach and device values depend on whether an image-guided percutaneous probe, an endoscopic device, or an open technique was used.
The most frequent error is coding Destruction when any portion of tissue was actually cut out and removed for pathology, which instead falls under Excision or Resection. When a biopsy is taken from the same lesion before it is ablated, that sampling should be coded separately as an Excision.